Live Quote · OTCVICPHealthcare· Biotechnology

Vicapsys Life Sciences, Inc.

$1.46 0.00%(+$0.00)
TickerSpark Score
34/100
Poor
20
Valuation
40
Profitability
60
Growth
20
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VICP research report →

52-Week Range81% of range
Low
$0.15
Current
$1.46
High
$1.77
Company Overviewvicapsys.com

About the company

Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses.

CEO
Federico Pier
IPO
1998
Employees
2
HQ
Cumming, GA, US

Price Chart

-17.51% · this period
$1.77$0.96$0.15Jul 02Dec 31Jul 02
Valuation
Market Cap
$47.26M
P/E
-117.74
P/S
0.00
P/B
-16.85
EV/EBITDA
-118.98
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
14.08%
ROIC
16.18%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-689,887 · 30.30%
EPS
$-0.02 · 32.29%
Op Income
$-651,803
FCF YoY
82.36%
Performance & Tape
52W High
$1.77
52W Low
$0.15
50D MA
$1.46
200D MA
$1.50
Beta
-4.13
Avg Volume
118.736

Get TickerSpark's AI analysis on VICP

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 20, 20Wildcat Capital Management, LLCother0
Sep 3, 10YURKOWSKI MICHAELsell5,000
Aug 9, 10YURKOWSKI MICHAELsell20,000
May 13, 10MOORE BOBBY M JRother0
Jan 26, 10YURKOWSKI MICHAELother5,000
Jan 14, 10YURKOWSKI MICHAELsell5,000
Nov 18, 09REES RODGERother50,000
Dec 8, 09SEDDON RYANother0
Jun 30, 09SEDDON RYANother500,000
Dec 8, 09PIER FEDERICOother0
Coverage · VICP

Our VICP coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on VICP yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate VICP report →
Internal Compare

Similar companies

Peers in the same neighborhood.